PER-004-03已完成1 期
DOUBLE-BLIND, PLACEBO CONTROLLED, RANDOMIZED, MULTICENTRIC STUDY TO EVALUATE THE SECURITY AND EFFICACY OF 2 MG 3 TIMES PER DAY OF CILANSETRON FOR 12 WEEKS, FOLLOWED BY A RANDOMIZED 4-WEEK TREATMENT PERIOD IN SUBJECTS WITH IRRITABLE COLON SYNDROME WITH PREDOMINANCE DIARRHEAL.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Patients with SCI who meet the 1992 Rome Criteria of SCI; the subpopulation with predominance of diarrhea is defined according to criteria II of Rome; The minimum frequency and consistency of bowel movements and abdominal pain during the pre-randomization period will be determined.
排除标准
- •Evidence of severe cardiovascular, respiratory, urogenital, gastrointestinal / hepatic, hematological / immunological disease.
- •Women who are pregnant or nursing.
- •History of drug or alcohol abuse.
- •Treatment with any investigational drug within four weeks
- •prior to inclusion in the study.
研究者
相似试验
进行中（未招募）
1 期
Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients with mild Alzheimer's Disease (STEADFAST)EUCTR2016-002005-19-IEvTv THERAPEUTICS LLC800
进行中（未招募）
1 期
Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients with mild Alzheimer's Disease (STEADFAST)MILD ALZHEIMER'S DISEASE RECEIVING ACETYLCHOLINESTERASE INHIBITORS AND/OR MEMANTINEMedDRA version: 20.0Level: PTClassification code 10012271Term: Dementia Alzheimer's typeSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: HLTClassification code 10001897Term: Alzheimer's disease (incl subtypes)System Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: HLTClassification code 10012268Term: Dementia (excl Alzheimer's type)System Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10012296Term: Dementia of the Alzheimer's type, with depressed moodSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10012295Term: Dementia of the Alzheimer's type, with delusionsSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10012294Term: Dementia of the Alzheimer's type, with deliriumSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10012293Term: Dementia of the Alzheimer's type, uncomplicatedSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: LLTClassification code 10012292Term: Dementia of the Alzheimer's type NOSSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: LLTClassification code 10066571Term: Progression of Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2016-002005-19-GBvTv THERAPEUTICS LLC800
已完成
不适用
Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder-F31F31PER-070-06OVARTIS BIOSCIENSES PERU S.A.,
未知
不适用
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE IIB DOSE FINDING STUDY OF GLPG0634 ADMINISTERED FOR 24 WEEKS IN COMBINATION WITH METHOTREXATE TO SUBJECTS WITHMODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAVE AN INADEQUATE RESPONSE TO METHOTREXATE ALONE-M06M06PER-057-13Galapagos N.V,
进行中（未招募）
不适用
RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTINATIONAL, MULTI-CENTRE, PHASE IIB/III STUDY OF THE EFFICACY AND SAFETY OF THREE DOSES OF SLIT ADMINISTERED AS TABLETS ONCE DAILY TO PATIENTS SUFFERING FROM GRASSES POLLEN RHINOCONJUNCTIVITISEUCTR2004-001910-15-ITSTALLERGENES